A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.

NCT03108534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: CHF1535 NEXThaler
DRUG: CHF1535 pMDI
DRUG: Placebo

Sponsor

Chiesi Farmaceutici S.p.A.